Paul  A Jerabek, Ph.D.

Dr. Paul Jerabek's research focuses on the synthesis and development of positron-emitting radio-pharmaceuticals for application to positron emission tomography (PET) studies. 

PET has the unique ability to image biochemical and biological processes of the living human body that are fundamental to disease and understanding the normal function of various organ systems of the body. For example, PET has shown to be especially useful to image neurological and psychiatric disorders, heart disease, and cancer.

• Professional Background

  Education

  • 1982 - PhD - Chemistry - University of California
  • 1974 - BS - Chemistry - Lewis and Clark College

  Appointments

  • 9/2001 - Associate Professor - University of Texas Health Science Center, Radiology, San Antonio

• Instruction & Training

  • 1/2010-present, Phys Nuclear Medi Imaging, The University of Texas Health Science Center San Antonio

• Publications

  D. Shengwen, D. Jiang, C. Franklin, M. O’Boyle, W. Zhang, B. Heyl, G. Fulbright, P. Jerabek, H. Lu, P. Fox. Whole Brain Aerobic Glycolysis Indicies Measured with MRI and 18FDG PET: PreliminarValidation Internat Soc Magn Reson Med Apr 2020